Global Prostate Cancer Diagnostics Solution Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 102

Published Date: 02 Apr 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Prostate Cancer Diagnostics Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prostate Cancer Diagnostics Solution market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Age Below 55 accounting for  % of the Prostate Cancer Diagnostics Solution global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Tumor Biomarker Tests segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Prostate Cancer Diagnostics Solution include OPKO, Genomic Health, Abbott, Beckman Coulter, and Siemens Healthcare, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Prostate Cancer Diagnostics Solution market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Tumor Biomarker Tests
    Imaging
    Biopsy
    Other

Market segment by Application, can be divided into
    Age Below 55
    Age 55-75
    Age Above 75

Market segment by players, this report covers
    OPKO
    Genomic Health
    Abbott
    Beckman Coulter
    Siemens Healthcare
    bioMeriux
    Roche
    MDx Health
    DiaSorin
    Myriad Genetics
    Ambry Genetics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostate Cancer Diagnostics Solution product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostate Cancer Diagnostics Solution, with revenue, gross margin and global market share of Prostate Cancer Diagnostics Solution from 2019 to 2022.
Chapter 3, the Prostate Cancer Diagnostics Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Prostate Cancer Diagnostics Solution market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Prostate Cancer Diagnostics Solution research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Prostate Cancer Diagnostics Solution
    1.2 Classification of Prostate Cancer Diagnostics Solution by Type
        1.2.1 Overview: Global Prostate Cancer Diagnostics Solution Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type in 2021
        1.2.3 Tumor Biomarker Tests
        1.2.4 Imaging
        1.2.5 Biopsy
        1.2.6 Other
    1.3 Global Prostate Cancer Diagnostics Solution Market by Application
        1.3.1 Overview: Global Prostate Cancer Diagnostics Solution Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Age Below 55
        1.3.3 Age 55-75
        1.3.4 Age Above 75
    1.4 Global Prostate Cancer Diagnostics Solution Market Size & Forecast
    1.5 Global Prostate Cancer Diagnostics Solution Market Size and Forecast by Region
        1.5.1 Global Prostate Cancer Diagnostics Solution Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Prostate Cancer Diagnostics Solution Market Size by Region, (2017-2022)
        1.5.3 North America Prostate Cancer Diagnostics Solution Market Size and Prospect (2017-2028)
        1.5.4 Europe Prostate Cancer Diagnostics Solution Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size and Prospect (2017-2028)
        1.5.6 South America Prostate Cancer Diagnostics Solution Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Prostate Cancer Diagnostics Solution Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Prostate Cancer Diagnostics Solution Market Drivers
        1.6.2 Prostate Cancer Diagnostics Solution Market Restraints
        1.6.3 Prostate Cancer Diagnostics Solution Trends Analysis

2 Company Profiles
    2.1 OPKO
        2.1.1 OPKO Details
        2.1.2 OPKO Major Business
        2.1.3 OPKO Prostate Cancer Diagnostics Solution Product and Solutions
        2.1.4 OPKO Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 OPKO Recent Developments and Future Plans
    2.2 Genomic Health
        2.2.1 Genomic Health Details
        2.2.2 Genomic Health Major Business
        2.2.3 Genomic Health Prostate Cancer Diagnostics Solution Product and Solutions
        2.2.4 Genomic Health Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Genomic Health Recent Developments and Future Plans
    2.3 Abbott
        2.3.1 Abbott Details
        2.3.2 Abbott Major Business
        2.3.3 Abbott Prostate Cancer Diagnostics Solution Product and Solutions
        2.3.4 Abbott Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Abbott Recent Developments and Future Plans
    2.4 Beckman Coulter
        2.4.1 Beckman Coulter Details
        2.4.2 Beckman Coulter Major Business
        2.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Product and Solutions
        2.4.4 Beckman Coulter Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Beckman Coulter Recent Developments and Future Plans
    2.5 Siemens Healthcare
        2.5.1 Siemens Healthcare Details
        2.5.2 Siemens Healthcare Major Business
        2.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Product and Solutions
        2.5.4 Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Siemens Healthcare Recent Developments and Future Plans
    2.6 bioMeriux
        2.6.1 bioMeriux Details
        2.6.2 bioMeriux Major Business
        2.6.3 bioMeriux Prostate Cancer Diagnostics Solution Product and Solutions
        2.6.4 bioMeriux Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 bioMeriux Recent Developments and Future Plans
    2.7 Roche
        2.7.1 Roche Details
        2.7.2 Roche Major Business
        2.7.3 Roche Prostate Cancer Diagnostics Solution Product and Solutions
        2.7.4 Roche Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Roche Recent Developments and Future Plans
    2.8 MDx Health
        2.8.1 MDx Health Details
        2.8.2 MDx Health Major Business
        2.8.3 MDx Health Prostate Cancer Diagnostics Solution Product and Solutions
        2.8.4 MDx Health Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 MDx Health Recent Developments and Future Plans
    2.9 DiaSorin
        2.9.1 DiaSorin Details
        2.9.2 DiaSorin Major Business
        2.9.3 DiaSorin Prostate Cancer Diagnostics Solution Product and Solutions
        2.9.4 DiaSorin Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 DiaSorin Recent Developments and Future Plans
    2.10 Myriad Genetics
        2.10.1 Myriad Genetics Details
        2.10.2 Myriad Genetics Major Business
        2.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Product and Solutions
        2.10.4 Myriad Genetics Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Myriad Genetics Recent Developments and Future Plans
    2.11 Ambry Genetics
        2.11.1 Ambry Genetics Details
        2.11.2 Ambry Genetics Major Business
        2.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Product and Solutions
        2.11.4 Ambry Genetics Prostate Cancer Diagnostics Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Ambry Genetics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Prostate Cancer Diagnostics Solution Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Prostate Cancer Diagnostics Solution Players Market Share in 2021
        3.2.2 Top 10 Prostate Cancer Diagnostics Solution Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Prostate Cancer Diagnostics Solution Players Head Office, Products and Services Provided
    3.4 Prostate Cancer Diagnostics Solution Mergers & Acquisitions
    3.5 Prostate Cancer Diagnostics Solution New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Prostate Cancer Diagnostics Solution Revenue and Market Share by Type (2017-2022)
    4.2 Global Prostate Cancer Diagnostics Solution Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2017-2022)
    5.2 Global Prostate Cancer Diagnostics Solution Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Prostate Cancer Diagnostics Solution Revenue by Type (2017-2028)
    6.2 North America Prostate Cancer Diagnostics Solution Revenue by Application (2017-2028)
    6.3 North America Prostate Cancer Diagnostics Solution Market Size by Country
        6.3.1 North America Prostate Cancer Diagnostics Solution Revenue by Country (2017-2028)
        6.3.2 United States Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        6.3.3 Canada Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        6.3.4 Mexico Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Prostate Cancer Diagnostics Solution Revenue by Type (2017-2028)
    7.2 Europe Prostate Cancer Diagnostics Solution Revenue by Application (2017-2028)
    7.3 Europe Prostate Cancer Diagnostics Solution Market Size by Country
        7.3.1 Europe Prostate Cancer Diagnostics Solution Revenue by Country (2017-2028)
        7.3.2 Germany Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        7.3.3 France Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        7.3.5 Russia Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        7.3.6 Italy Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Type (2017-2028)
    8.2 Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Application (2017-2028)
    8.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region
        8.3.1 Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Region (2017-2028)
        8.3.2 China Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        8.3.3 Japan Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        8.3.4 South Korea Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        8.3.5 India Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        8.3.7 Australia Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Prostate Cancer Diagnostics Solution Revenue by Type (2017-2028)
    9.2 South America Prostate Cancer Diagnostics Solution Revenue by Application (2017-2028)
    9.3 South America Prostate Cancer Diagnostics Solution Market Size by Country
        9.3.1 South America Prostate Cancer Diagnostics Solution Revenue by Country (2017-2028)
        9.3.2 Brazil Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        9.3.3 Argentina Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Type (2017-2028)
    10.2 Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Application (2017-2028)
    10.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country
        10.3.1 Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Country (2017-2028)
        10.3.2 Turkey Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)
        10.3.4 UAE Prostate Cancer Diagnostics Solution Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Prostate Cancer Diagnostics Solution Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Prostate Cancer Diagnostics Solution Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Prostate Cancer Diagnostics Solution Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Prostate Cancer Diagnostics Solution Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Region (2023-2028)
    Table 6. OPKO Corporate Information, Head Office, and Major Competitors
    Table 7. OPKO Major Business
    Table 8. OPKO Prostate Cancer Diagnostics Solution Product and Solutions
    Table 9. OPKO Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Genomic Health Corporate Information, Head Office, and Major Competitors
    Table 11. Genomic Health Major Business
    Table 12. Genomic Health Prostate Cancer Diagnostics Solution Product and Solutions
    Table 13. Genomic Health Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Abbott Corporate Information, Head Office, and Major Competitors
    Table 15. Abbott Major Business
    Table 16. Abbott Prostate Cancer Diagnostics Solution Product and Solutions
    Table 17. Abbott Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Beckman Coulter Corporate Information, Head Office, and Major Competitors
    Table 19. Beckman Coulter Major Business
    Table 20. Beckman Coulter Prostate Cancer Diagnostics Solution Product and Solutions
    Table 21. Beckman Coulter Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
    Table 23. Siemens Healthcare Major Business
    Table 24. Siemens Healthcare Prostate Cancer Diagnostics Solution Product and Solutions
    Table 25. Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. bioMeriux Corporate Information, Head Office, and Major Competitors
    Table 27. bioMeriux Major Business
    Table 28. bioMeriux Prostate Cancer Diagnostics Solution Product and Solutions
    Table 29. bioMeriux Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Roche Corporate Information, Head Office, and Major Competitors
    Table 31. Roche Major Business
    Table 32. Roche Prostate Cancer Diagnostics Solution Product and Solutions
    Table 33. Roche Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. MDx Health Corporate Information, Head Office, and Major Competitors
    Table 35. MDx Health Major Business
    Table 36. MDx Health Prostate Cancer Diagnostics Solution Product and Solutions
    Table 37. MDx Health Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. DiaSorin Corporate Information, Head Office, and Major Competitors
    Table 39. DiaSorin Major Business
    Table 40. DiaSorin Prostate Cancer Diagnostics Solution Product and Solutions
    Table 41. DiaSorin Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Myriad Genetics Corporate Information, Head Office, and Major Competitors
    Table 43. Myriad Genetics Major Business
    Table 44. Myriad Genetics Prostate Cancer Diagnostics Solution Product and Solutions
    Table 45. Myriad Genetics Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Ambry Genetics Corporate Information, Head Office, and Major Competitors
    Table 47. Ambry Genetics Major Business
    Table 48. Ambry Genetics Prostate Cancer Diagnostics Solution Product and Solutions
    Table 49. Ambry Genetics Prostate Cancer Diagnostics Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Global Prostate Cancer Diagnostics Solution Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 51. Global Prostate Cancer Diagnostics Solution Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 52. Breakdown of Prostate Cancer Diagnostics Solution by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 53. Prostate Cancer Diagnostics Solution Players Head Office, Products and Services Provided
    Table 54. Prostate Cancer Diagnostics Solution Mergers & Acquisitions in the Past Five Years
    Table 55. Prostate Cancer Diagnostics Solution New Entrants and Expansion Plans
    Table 56. Global Prostate Cancer Diagnostics Solution Revenue (USD Million) by Type (2017-2022)
    Table 57. Global Prostate Cancer Diagnostics Solution Revenue Share by Type (2017-2022)
    Table 58. Global Prostate Cancer Diagnostics Solution Revenue Forecast by Type (2023-2028)
    Table 59. Global Prostate Cancer Diagnostics Solution Revenue by Application (2017-2022)
    Table 60. Global Prostate Cancer Diagnostics Solution Revenue Forecast by Application (2023-2028)
    Table 61. North America Prostate Cancer Diagnostics Solution Revenue by Type (2017-2022) & (USD Million)
    Table 62. North America Prostate Cancer Diagnostics Solution Revenue by Type (2023-2028) & (USD Million)
    Table 63. North America Prostate Cancer Diagnostics Solution Revenue by Application (2017-2022) & (USD Million)
    Table 64. North America Prostate Cancer Diagnostics Solution Revenue by Application (2023-2028) & (USD Million)
    Table 65. North America Prostate Cancer Diagnostics Solution Revenue by Country (2017-2022) & (USD Million)
    Table 66. North America Prostate Cancer Diagnostics Solution Revenue by Country (2023-2028) & (USD Million)
    Table 67. Europe Prostate Cancer Diagnostics Solution Revenue by Type (2017-2022) & (USD Million)
    Table 68. Europe Prostate Cancer Diagnostics Solution Revenue by Type (2023-2028) & (USD Million)
    Table 69. Europe Prostate Cancer Diagnostics Solution Revenue by Application (2017-2022) & (USD Million)
    Table 70. Europe Prostate Cancer Diagnostics Solution Revenue by Application (2023-2028) & (USD Million)
    Table 71. Europe Prostate Cancer Diagnostics Solution Revenue by Country (2017-2022) & (USD Million)
    Table 72. Europe Prostate Cancer Diagnostics Solution Revenue by Country (2023-2028) & (USD Million)
    Table 73. Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Type (2017-2022) & (USD Million)
    Table 74. Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Type (2023-2028) & (USD Million)
    Table 75. Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Application (2017-2022) & (USD Million)
    Table 76. Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Application (2023-2028) & (USD Million)
    Table 77. Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Region (2017-2022) & (USD Million)
    Table 78. Asia-Pacific Prostate Cancer Diagnostics Solution Revenue by Region (2023-2028) & (USD Million)
    Table 79. South America Prostate Cancer Diagnostics Solution Revenue by Type (2017-2022) & (USD Million)
    Table 80. South America Prostate Cancer Diagnostics Solution Revenue by Type (2023-2028) & (USD Million)
    Table 81. South America Prostate Cancer Diagnostics Solution Revenue by Application (2017-2022) & (USD Million)
    Table 82. South America Prostate Cancer Diagnostics Solution Revenue by Application (2023-2028) & (USD Million)
    Table 83. South America Prostate Cancer Diagnostics Solution Revenue by Country (2017-2022) & (USD Million)
    Table 84. South America Prostate Cancer Diagnostics Solution Revenue by Country (2023-2028) & (USD Million)
    Table 85. Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Type (2017-2022) & (USD Million)
    Table 86. Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Type (2023-2028) & (USD Million)
    Table 87. Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Application (2017-2022) & (USD Million)
    Table 88. Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Application (2023-2028) & (USD Million)
    Table 89. Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Country (2017-2022) & (USD Million)
    Table 90. Middle East & Africa Prostate Cancer Diagnostics Solution Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Prostate Cancer Diagnostics Solution Picture
    Figure 2. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type in 2021
    Figure 3. Tumor Biomarker Tests
    Figure 4. Imaging
    Figure 5. Biopsy
    Figure 6. Other
    Figure 7. Prostate Cancer Diagnostics Solution Revenue Market Share by Application in 2021
    Figure 8. Age Below 55 Picture
    Figure 9. Age 55-75 Picture
    Figure 10. Age Above 75 Picture
    Figure 11. Global Prostate Cancer Diagnostics Solution Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 12. Global Prostate Cancer Diagnostics Solution Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Region (2017-2028)
    Figure 14. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Region in 2021
    Figure 15. North America Prostate Cancer Diagnostics Solution Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. Europe Prostate Cancer Diagnostics Solution Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Asia-Pacific Prostate Cancer Diagnostics Solution Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. South America Prostate Cancer Diagnostics Solution Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Middle East and Africa Prostate Cancer Diagnostics Solution Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Prostate Cancer Diagnostics Solution Market Drivers
    Figure 21. Prostate Cancer Diagnostics Solution Market Restraints
    Figure 22. Prostate Cancer Diagnostics Solution Market Trends
    Figure 23. OPKO Recent Developments and Future Plans
    Figure 24. Genomic Health Recent Developments and Future Plans
    Figure 25. Abbott Recent Developments and Future Plans
    Figure 26. Beckman Coulter Recent Developments and Future Plans
    Figure 27. Siemens Healthcare Recent Developments and Future Plans
    Figure 28. bioMeriux Recent Developments and Future Plans
    Figure 29. Roche Recent Developments and Future Plans
    Figure 30. MDx Health Recent Developments and Future Plans
    Figure 31. DiaSorin Recent Developments and Future Plans
    Figure 32. Myriad Genetics Recent Developments and Future Plans
    Figure 33. Ambry Genetics Recent Developments and Future Plans
    Figure 34. Global Prostate Cancer Diagnostics Solution Revenue Share by Players in 2021
    Figure 35. Prostate Cancer Diagnostics Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 36. Global Top 3 Players Prostate Cancer Diagnostics Solution Revenue Market Share in 2021
    Figure 37. Global Top 10 Players Prostate Cancer Diagnostics Solution Revenue Market Share in 2021
    Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 39. Global Prostate Cancer Diagnostics Solution Revenue Share by Type in 2021
    Figure 40. Global Prostate Cancer Diagnostics Solution Market Share Forecast by Type (2023-2028)
    Figure 41. Global Prostate Cancer Diagnostics Solution Revenue Share by Application in 2021
    Figure 42. Global Prostate Cancer Diagnostics Solution Market Share Forecast by Application (2023-2028)
    Figure 43. North America Prostate Cancer Diagnostics Solution Sales Market Share by Type (2017-2028)
    Figure 44. North America Prostate Cancer Diagnostics Solution Sales Market Share by Application (2017-2028)
    Figure 45. North America Prostate Cancer Diagnostics Solution Revenue Market Share by Country (2017-2028)
    Figure 46. United States Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. Canada Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Mexico Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Europe Prostate Cancer Diagnostics Solution Sales Market Share by Type (2017-2028)
    Figure 50. Europe Prostate Cancer Diagnostics Solution Sales Market Share by Application (2017-2028)
    Figure 51. Europe Prostate Cancer Diagnostics Solution Revenue Market Share by Country (2017-2028)
    Figure 52. Germany Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. France Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. United Kingdom Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Russia Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Italy Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Asia-Pacific Prostate Cancer Diagnostics Solution Sales Market Share by Type (2017-2028)
    Figure 58. Asia-Pacific Prostate Cancer Diagnostics Solution Sales Market Share by Application (2017-2028)
    Figure 59. Asia-Pacific Prostate Cancer Diagnostics Solution Revenue Market Share by Region (2017-2028)
    Figure 60. China Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Japan Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South Korea Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. India Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Southeast Asia Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Australia Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. South America Prostate Cancer Diagnostics Solution Sales Market Share by Type (2017-2028)
    Figure 67. South America Prostate Cancer Diagnostics Solution Sales Market Share by Application (2017-2028)
    Figure 68. South America Prostate Cancer Diagnostics Solution Revenue Market Share by Country (2017-2028)
    Figure 69. Brazil Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Argentina Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Middle East and Africa Prostate Cancer Diagnostics Solution Sales Market Share by Type (2017-2028)
    Figure 72. Middle East and Africa Prostate Cancer Diagnostics Solution Sales Market Share by Application (2017-2028)
    Figure 73. Middle East and Africa Prostate Cancer Diagnostics Solution Revenue Market Share by Country (2017-2028)
    Figure 74. Turkey Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Saudi Arabia Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. UAE Prostate Cancer Diagnostics Solution Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics

Related Reports

Global Prostate Cancer Diagnostics Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Prostate Cancer Diagnostics Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 26 Feb 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics Solution market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Prostate Cancer Diagnostics Solution Supply, Demand and Key Producers, 2023-2029

Global Prostate Cancer Diagnostics Solution Supply, Demand and Key Producers, 2023-2029

date 21 Jan 2023

date Medical Devices & Consumables

The global Prostate Cancer Diagnostics Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Prostate Cancer Diagnostics Solution Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Prostate Cancer Diagnostics Solution Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics Solution market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period.

Global Prostate Cancer Diagnostics Solution Supply, Demand and Key Producers, 2024-2030

Global Prostate Cancer Diagnostics Solution Supply, Demand and Key Producers, 2024-2030

date 15 Feb 2024

date Medical Devices & Consumables

The global Prostate Cancer Diagnostics Solution market size is expected to reach $ 22870 million by 2030, rising at a market growth of 7.5% CAGR during the forecast period (2024-2030).

Product Tags

prostate cancer diagnostics solution

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>